MARK RESTAD: Open Payments
NPI 1114145174 · KENAI, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 10 payments from 7 companies in 2025. Trend: 2023 $401 · 2024 $420 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $177 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| ABBVIE INC. | 2 | $57 |
| Amgen Inc. | 1 | $29 |
| 3B Medical, Inc. | 1 | $27 |
| Indivior Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: CAMZYOS, BREZTRI, UBRELVY, AIRSUPRA, EVENITY, LUNA, SUBLOCADE, GVOKE HYPOPEN.
Industry payments across AK — which companies pay providers there.
